Medifast Inc [NYSE: MED] gained 0.55% on the last trading session, reaching $10.97 price per share at the time.
Medifast Inc represents 10.99 million in outstanding shares, while the company has a total market value of $120.57 million with the latest information. MED stock price has been found in the range of $10.88 to $11.06.
If compared to the average trading volume of 164.20K shares, MED reached a trading volume of 153560 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Medifast Inc [MED]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MED shares is $15.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MED stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
DA Davidson have made an estimate for Medifast Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on November 05, 2024. While these analysts kept the previous recommendation, DA Davidson dropped their target price from $25 to $17.50. The new note on the price target was released on June 05, 2024, representing the official price target for Medifast Inc stock. Previously, the target price had yet another raise to $82, while Stephens analysts kept a Equal-Weight rating on MED stock. On November 04, 2022, analysts decreased their price target for MED shares from 278 to 106.
The Price to Book ratio for the last quarter was 0.56, with the Price to Cash per share for the same quarter was set at 15.79. Price to Free Cash Flow for MED in the course of the last twelve months was 185.49 with Quick ratio for the last quarter at 3.95.
Trading performance analysis for MED stock
Medifast Inc [MED] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.86. With this latest performance, MED shares dropped by -13.83% in over the last four-week period, additionally sinking by -21.31% over the last 6 months – not to mention a drop of -37.74% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MED stock in for the last two-week period is set at 35.83, with the RSI for the last a single of trading hit 0.39, and the three-weeks RSI is set at 0.43 for Medifast Inc [MED]. The present Moving Average for the last 50 days of trading for this stock 12.62, while it was recorded at 10.71 for the last single week of trading, and 13.44 for the last 200 days.
Medifast Inc [MED]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Medifast Inc [MED] shares currently have an operating margin of -1.33% and a Gross Margin at 72.44%. Medifast Inc’s Net Margin is presently recorded at 0.06%.
Medifast Inc (MED) Capital Structure & Debt Analysis
According to recent financial data for Medifast Inc. ( MED), the Return on Equity (ROE) stands at 0.12%, suggesting modest shareholder returns. The Return on Assets (ROA) is 0.09%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Medifast Inc’s Return on Invested Capital (ROIC) is 0.11%, showcasing its effectiveness in deploying capital for earnings.
Medifast Inc (MED) Efficiency & Liquidity Metrics
Based on Medifast Inc’s (MED) latest financial statements, the Debt-to-Equity Ratio is 0.06%, indicating its reliance on debt financing relative to shareholder equity.
Medifast Inc (MED) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Medifast Inc. (MED) effectively leverages its workforce, generating an average of $496.03 per employee. The company’s liquidity position is robust, with a Current Ratio of 4.45% and a Quick Ratio of 3.95%, indicating strong ability to cover short-term liabilities.
Medifast Inc [MED]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Medifast Inc posted 0.1/share EPS, while the average EPS was predicted by analysts to be reported at -0.16/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.26. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MED.
An analysis of Institutional ownership at Medifast Inc [MED]
There are presently around $85.89%, or 88.73%% of MED stock, in the hands of institutional investors. The top three institutional holders of MED stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 0.96 million shares, which is approximately 8.7648%. BLACKROCK INC., holding 0.83 million shares of the stock with an approximate value of $$18.09 million in MED stocks shares; and BLACKROCK INC., currently with $$15.78 million in MED stock with ownership which is approximately 6.6135%.
